Max Wallace, CEO of Accelerate Brain Cancer Cure, uses a football analogy when explaining his foundation’s approach to funding life sciences research.
Large companies aren’t getting into the game, which they see as too risky. But the stakes are high because patients are dying. Accelerate Brain Cancer Cure steps in to try and help researchers get into the end zone. Quickly. Accelerate Brain Cancer Cure is not interested in incremental developments that move the ball down the field a few yards at a time. It’s looking for medical breakthroughs.
To read the full, original article click on this link: 4 tips for life sciences companies seeking foundation funding
